Searching for a cure, Improving lives

What is Duchenne Muscular Dystrophy?

 

 

Duchenne muscular dystrophy is the most common fatal genetic disorder diagnosed in childhood, affecting approximately 1 in every 3,500 live male births (around 2500 people have DMD in the UK).

Because the Duchenne gene is found on the X-chromosome, it primarily affects boys with less than 1% of those with Duchenne being female. However, it occurs across all races and cultures.

Duchenne results in progressive loss of strength and is caused by a mutation in the gene that encodes for dystrophin. Because dystrophin is absent, the muscle cells are easily damaged. The progressive muscle weakness leads to serious medical problems, particularly issues relating to the heart and lungs. Young men with Duchenne typically live into their late twenties. Life expectancy is improving as standards of care and knowledge about Duchenne increases , and some men live into their 30’s and 40’s

Becker muscular dystrophy, which is less severe than Duchenne, occurs when dystrophin is manufactured, but not in the normal form or amount. Because of this disparity in the severity of the different forms of these disorders, we will refer primarily to Duchenne throughout this site.

Duchenne can be passed from parent to child, but approximately 35% of cases occur because of a random spontaneous mutation. In other words, it can affect anyone.

Although there are medical treatments that may help slow its progression, there is currently no cure for Duchenne.

Action Duchenne is a UK charity founded in 2001 to fund research to find a cure or viable treatments for Duchenne Muscular Dystrophy. Since 2001 the charity has grown and continues to fund cutting edge research while campaigning for the best standards of care to be made available for all living with Duchenne. We also run education and transition projects for young people living with DMD and our community.

If your child has been diagnosed with Duchenne please get in contact. We have a range of useful information for parents, your child can be added to the DMD registry to ensure they can be put forward for any suitable clinical trials , and we may be able to answer your questions or put you in touch with people that can help.

A huge amount of information on the condition and how it should be managed can be found in the Family Guide which is available to view and download here : http://www.dmd-guide.org/  .

 

 

 

Donate

Support Action Duchenne with a monthly or one off donation

Donate

Events

View our events

View All Events

Registry

Join the DMD registry for access to clinical trials

Register

Long-term microdystrophin pre-clinical work, moving towards a potential therapy restores muscle function in canines

July 26th, 2017

Promising microdystrophin pre-clinical work, moving towards a potential therapy has shown to restore muscle function

Tell me more

First draft of agenda announced – Action Duchenne International Conference

June 28th, 2017

We are extremely excited to announce the first draft of the agenda for the Action

Tell me more

Sarepta announces its partner, Genethon, published new micro-dystrophin gene therapy data

July 28th, 2017

Data show for the first time a systemic therapeutic effect in DMD dogs using a

Tell me more

Duchenne – How do you measure a life?

Living with Duchenne – an animation

Taking charge of Duchenne

wordpress counter

Stay informed with regular updates from Action Duchenne